The oral MDM2/p53 antagonist BI 907828 elicited preliminary antitumor activity and had a manageable safety profile in patients with MDM2-amplified dedifferentiated liposarcoma.
In this article, Jinwei Bio discusses lentiviral vectors, providing a brief introduction into what they are and how they can be utilized within the life sciences.